Loading clinical trials...
Loading clinical trials...
A Randomized, Multicenter, Open-Label, Parallel-Group Clinical Study Comparing the Safety and Efficacy of MYL-1601D With NovoLog® in Type 1 Diabetes Mellitus Patients
Conditions
Interventions
MYL-1601D Product
FlexPen NovoLog®
Locations
158
United States
Endocrinology Associates Montgomery
Montgomery, Alabama, United States
Phoenician Centers for Research
Phoenix, Arizona, United States
Precision Trials
Phoenix, Arizona, United States
Medical Investigations Inc.
Little Rock, Arkansas, United States
John Muir Physician Network
Concord, California, United States
Valley Research
Fresno, California, United States
Start Date
November 7, 2018
Primary Completion Date
December 28, 2019
Completion Date
January 17, 2020
Last Updated
February 25, 2022
NCT06807190
NCT04786262
NCT06748963
NCT06329375
NCT06945406
NCT06325202
Lead Sponsor
Mylan Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions